期刊文献+

丹参酮ⅡA衍生物的合成与放射增敏活性测定 被引量:1

Synthesis of TanshinoneⅡΑ Derivatives and Their Radiosensitivity Against Hela Cells
下载PDF
导出
摘要 目的对丹参酮ⅡA进行结构修饰,以期得到放射增敏效果较好的衍生物。方法通过曼尼希反应在丹参酮ⅡA的16位引入不同的小分子胺,通过EI-MS、1HNMR确证化合物结构,通过噻唑蓝(MTT)法测定其对Hela细胞的半数抑制浓度(IC50)及20%抑制浓度(IC20)值,初步评价几种衍生物的放射增敏活性。结果得到丹参酮的5个化合物,其中4个未见文献报道。其中3个进行了放射增敏活性测定,发现在16位引入芳香环的衍生物C5放射增敏效果增强。结论在16位引入芳香环可能是提高药物放射增敏活性的一种方式。 Objective Structure modification of Tanshinone ⅡA was performed in order to get tanshinone derivativeswith higher radiosensitivity. Methods Structure of Tanshinone ⅡA was modified via Mannich reaction by adding differentsmall amines at C16. The structures of the derivatives were confirmed through spectral data of EI-MS and 1 HNMR. The antiprolif-eration activities and radiosensitizing activity of Tanshinone ⅡA derivatives against Hela cells were evaluated by MTT assay atIC50 and IC20 . Results Five compounds were synthesized, four of which were new. Compound C5 with an aromatic nucleus in-serted at C16 had higher radiosensitivity than the prototype drug. Conclusion Adding an aromatic ring at position C16 of Tan-shinone ⅡA may be a good way for enhancing radiosensitizing activity.
出处 《医药导报》 CAS 北大核心 2014年第3期283-286,共4页 Herald of Medicine
基金 中国医学科学院放射医学研究所所内探索基金(ST1321)
关键词 丹参酮ⅡA 结构修饰 辐射增敏 Tanshinone ⅡA Structural modification Radiosensitizing activity
  • 相关文献

参考文献6

二级参考文献26

共引文献76

同被引文献11

  • 1BiHC(毕惠嫦).The pharmacokinetie study of tanshinone ⅡA in rats and the involved mechanisms. Guangzhou: Sun Yat-sen University (中山大学),PhD.2007.
  • 2Wang X, Morris-Natschke SL, Lee KH, et al. New develop- ments in the chemistry and biology of the bioacfive constitu- ents of Tanshen. Med Res Rev ,2007 ,27 :133-148.
  • 3Chen X, Guo J, Bao J, et al. The anticancer properties of Salvia miltiorrhiza Bunge (Danshen) :a systematic review. Med Res Rev ,2014 ,34:768-794.
  • 4Chen W,Lu Y, Chen G, et al. Molecular evidence of crypto- tanshinone for treatment and prevention of human cancer. An- tlcancer Agents Med Chem .2013.13:979-987.
  • 5Zhang Y, Jiang P, Ye M, et al. Tanshinoncs :sources, phanna- cokinetics and anti-cancer activities. Int J Mol Sci,2012,13 : 13621-13666.
  • 6Li GB, Shah CY, Liu L, et al. Tanshinone ⅡA inhibits HIF- 1α and VEGF expression in breast cancer cells via roTOR/pTOS6K/RPS6/4E-BP1 signaling pathway. PLoS One ,2015, 10(2) :e0117440.
  • 7Zhang Y, Wei R.X, Zhu XB, et al. Tanshinone ⅡA induces ap- optosis and inhibits the proliferation, migration, and invasion of the osteosarcoma MG-63 cell line in vitro. Anticancer Drugs,2012,23:212-219.
  • 8QinjK(覃江克).Studiesontheseparationsoftanshinonesandtheirchemicaltransformations.Guangzhou:SunYat-senUniversity(中山大学),PhD.2005.
  • 9江城锋,李瑞峰,薛丹,杨福军,沈秀,徐文清.丹参酮ⅡA结构修饰及其对HeLa细胞的抑制作用研究[J].天然产物研究与开发,2012,24(3):385-388. 被引量:6
  • 10郝文慧,赵文文,陈修平.丹参酮类抗肿瘤作用与机制研究进展[J].中国药理学通报,2014,30(8):1041-1044. 被引量:39

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部